Sidley Austin recruits Senger
This article was originally published in The Tan Sheet
Executive SummaryFDA's former acting chief counsel and deputy chief counsel Jeffrey Senger joins Sidley Austin's global food, drug and medical device regulatory practice in Washington. The firm's new partner "has an internal understanding of the FDA, combined with a handle on the complex regulatory and enforcement environments in which we work," said Raymond Bonner of Sidley's executive committee. The firm said Aug. 2 Senger also served 17 years in the Department of Justice. He was replaced as acting chief counsel at FDA in April 2009 by Michael Landa, now acting director of the Center for Food Safety and Applied Nutrition (1"The Tan Sheet" April 13, 2009)
You may also be interested in...
The pharmaceutical industry will be watching carefully as the EU Court of Justice deliberates on whether to deny or widen the granting of supplementary protection certificates on new therapeutic indications of authorized medicines.
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.